» Articles » PMID: 34095813

Differences in Performance on English and Hebrew Versions of the MoCA in Parkinson's Patients

Overview
Date 2021 Jun 7
PMID 34095813
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable.

Methods: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language.

Results: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRSIII), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, = 0.111).

Conclusion: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation.

Citing Articles

Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis.

Hsu J, Liu C, Chen I, Wu J, Huang P, Liu T Front Public Health. 2023; 11:1293710.

PMID: 38026272 PMC: 10644725. DOI: 10.3389/fpubh.2023.1293710.


The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.

Debroff J, Omer N, Cohen B, Giladi N, Kestenbaum M, Shirvan J Mov Disord Clin Pract. 2023; 10(4):606-616.

PMID: 37070047 PMC: 10105114. DOI: 10.1002/mdc3.13722.


Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the G2019S Variant.

Saunders-Pullman R, Ortega R, Wang C, Raymond D, Elango S, Leaver K Neurology. 2022; 99(8):e814-e823.

PMID: 35995594 PMC: 9484727. DOI: 10.1212/WNL.0000000000200737.


Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.

Ortega R, Wang C, Raymond D, Bryant N, Scherzer C, Thaler A JAMA Netw Open. 2021; 4(4):e215845.

PMID: 33881531 PMC: 8060834. DOI: 10.1001/jamanetworkopen.2021.5845.


The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?.

Rosenblum S, Meyer S, Gemerman N, Mentzer L, Richardson A, Israeli-Korn S Mov Disord Clin Pract. 2020; 7(6):648-655.

PMID: 32775510 PMC: 7396845. DOI: 10.1002/mdc3.12969.

References
1.
DAth P, Katona P, Mullan E, Evans S, Katona C . Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract. 1994; 11(3):260-6. DOI: 10.1093/fampra/11.3.260. View

2.
Beck A, Steer R, Ball R, Ranieri W . Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3):588-97. DOI: 10.1207/s15327752jpa6703_13. View

3.
Davis M, Johnson C, Leverenz J, Weintraub D, Trojanowski J, Chen-Plotkin A . Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. JAMA Neurol. 2016; 73(10):1217-1224. PMC: 5056861. DOI: 10.1001/jamaneurol.2016.2245. View

4.
Kave G . Phonemic fluency, semantic fluency, and difference scores: normative data for adult Hebrew speakers. J Clin Exp Neuropsychol. 2005; 27(6):690-9. DOI: 10.1080/13803390490918499. View

5.
Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View